Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors

被引：0
|
作者：
Jianhua Ma
Bin Zhang
Jianing Hou
Yongde Peng
机构：
[1] Nanjing First Hospital,Department of Endocrinology
[2] Lilly China Drug Development and Medical Affairs Center,Department of Endocrinology and Metabolism, Shanghai First People’s Hospital
[3] Shanghai Jiao Tong University,undefined
来源：
Diabetes Therapy | 2021年 / 12卷
关键词：
Dulaglutide; East Asian patients; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：211 / 222
页数：11
相关论文
共 50 条
  • [1] Efficacy and Safety of Once Weekly Dulaglutide in East Asian Patients with Type 2 Diabetes: Subgroup Analysis by Potential Influential Factors
    Ma, Jianhua
    Zhang, Bin
    Hou, Jianing
    Peng, Yongde
    [J]. DIABETES THERAPY, 2021, 12 (01) : 211 - 222
  • [2] Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors
    Zhou, Yan
    Zhu, Jiankun
    Wu, Haiya
    Deng, Yuying
    Ji, Qiuhe
    [J]. DIABETES THERAPY, 2021, 12 (10) : 2677 - 2690
  • [3] Pancreatic Safety of Once-Weekly Dulaglutide in Chinese Patients with Type 2 Diabetes Mellitus: Subgroup Analysis by Potential Influencing Factors
    Yan Zhou
    Jiankun Zhu
    Haiya Wu
    Yuying Deng
    Qiuhe Ji
    [J]. Diabetes Therapy, 2021, 12 : 2677 - 2690
  • [4] Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
    Yukiko Onishi
    Hitoshi Ishii
    Tomonori Oura
    Masakazu Takeuchi
    [J]. Diabetes Therapy, 2020, 11 : 735 - 745
  • [5] Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen
    Onishi, Yukiko
    Ishii, Hitoshi
    Oura, Tomonori
    Takeuchi, Masakazu
    [J]. DIABETES THERAPY, 2020, 11 (03) : 735 - 745
  • [6] The efficacy and safety of once-weekly, subcutaneous dulaglutide monotherapy compared to glimepiride in Asian patients with type 2 diabetes mellitus
    Wang, W.
    Huang, C. -N.
    Young, M. -C.
    Li, P.
    Gu, L.
    Yang, J.
    [J]. DIABETOLOGIA, 2015, 58 : S375 - S375
  • [7] Efficacy of once-weekly dulaglutide on HbA1c reduction in East Asian patients with T2DM: subgroup analysis according to potential influencing factors
    Peng, Yongde
    Zhang, Bin
    Hou, Jianing
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35
  • [8] Efficacy and Safety of Once-Weekly Dulaglutide vs. Once-Daily Liraglutide in Japanese Patients with Type 2 Diabetes
    Takamura, Toshinari
    Miyagawa, Jun-Ichiro
    Odawara, Masato
    Takita, Yasushi
    Iwamoto, Noriyuki
    Imaoka, Takeshi
    [J]. DIABETES, 2015, 64 : A285 - A285
  • [9] Efficacy and safety of once-weekly dulaglutide monotherapy compared to glimepiride in Chinese patients with type 2 diabetes mellitus
    Wang, Weiqing
    Li, Pengfei
    Yang, Jun
    Gu, Liqun
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2015, 31 : 10 - 11
  • [10] Efficacy and safety of once weekly dulaglutide versus once daily liraglutide in type 2 diabetes (AWARD6)
    Tofe Povedano, S.
    Dungan, K. M.
    Forst, T.
    Gonzalez Gonzalez, J. G.
    Atisso, C.
    Sealls, W.
    Fahrbach, J. L.
    [J]. DIABETOLOGIA, 2014, 57 : S23 - S23
12345